Linde Short-Term Borrowings decreased by 9.1% to $4.51B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $4.22B to $4.51B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 6.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.68B | $2.90B | $1.16B | $2.55B | $3.22B | $3.18B | $4.12B | $5.34B | $3.02B | $3.85B | $4.71B | $4.05B | $3.33B | $3.51B | $4.22B | $4.47B | $4.88B | $4.96B | $4.51B |
| QoQ Change | — | -21.4% | -59.8% | +119.2% | +26.1% | -1.1% | +29.5% | +29.6% | -43.5% | +27.5% | +22.4% | -14.2% | -17.8% | +5.5% | +20.3% | +5.7% | +9.3% | +1.7% | -9.1% |
| YoY Change | — | — | — | — | -12.7% | +9.8% | +254.0% | +109.4% | -6.1% | +21.1% | +14.5% | -24.2% | +10.2% | -8.8% | -10.4% | +10.4% | +46.7% | +41.4% | +6.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.